Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States
CONCLUSION: Our findings support the use of PD-1 blockade in HIV-cHL for the same indications as the general population with cHL.PMID:38714474 | DOI:10.1016/j.clml.2024.03.011
Source: The Medical Clinics of North America - Category: General Medicine Authors: Kathryn Lurain Talal El Zarif Ramya Ramaswami Amin H Nassar Elio Adib Noha Abdel-Wahab Nikita Chintapally Claire E Drolen Tatyana Feldman Tarek Haykal Caroline A Nebhan Swetha Kambhampati Mingjia Li Arjun Mittra Michael Lorentsen Chul Kim Alexandra Drakak Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Databases & Libraries | General Medicine | Hodgkin's Disease | Lymphoma | Myeloma | Study | USA Health